Pliant Therapeutics, Inc.
NASDAQ:PLRX
1.54 (USD) • At close March 14, 2025
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Omzet
| 0 | 1.58 | 9.685 | 7.572 | 41.817 | 57.052 | 0 | 0 |
| Kosten van de omzet
| 0 | 0 | 3.681 | 3.204 | 0 | 0 | 0.666 | 0 |
| Brutowinst
| 0 | 1.58 | 6.004 | 4.368 | 41.817 | 57.052 | -0.666 | 0 |
| Brutowinstmarge
| 0 | 1 | 0.62 | 0.577 | 1 | 1 | 0 | 0 |
| Onderzoek- en ontwikkelingskosten
| 169.31 | 127.797 | 96.936 | 77.549 | 66.193 | 47.353 | 24.415 | 14.526 |
| Algemene en administratieve kosten
| 59.055 | 57.928 | 39.949 | 27.558 | 17.269 | 10.93 | 6.5 | 3.823 |
| Verkoop- en marketingkosten
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verkoop-, algemene en administratieve kosten
| 59.055 | 57.928 | 39.949 | 27.558 | 17.269 | 10.93 | 6.5 | 3.823 |
| Overige kosten
| 0 | 0 | 0 | -77.549 | -0.366 | -0.216 | -0.049 | 0 |
| Bedrijfskosten
| 228.365 | 185.725 | 136.885 | 27.558 | 83.462 | 58.283 | 30.915 | 18.349 |
| Bedrijfsresultaat
| -228.365 | -184.145 | -127.2 | -19.986 | -41.645 | -1.231 | -30.915 | -18.349 |
| Bedrijfsresultaat ratio
| 0 | -116.547 | -13.134 | -2.639 | -0.996 | -0.022 | 0 | 0 |
| Totaal overige inkomsten en kosten netto
| 18.061 | 22.809 | 3.879 | 0.272 | 0.112 | 0.6 | 0.639 | 0.016 |
| Inkomen voor belasting
| -210.304 | -161.336 | -123.321 | -19.714 | -41.533 | -0.631 | -30.276 | -18.333 |
| Inkomen voor belasting ratio
| 0 | -102.111 | -12.733 | -2.604 | -0.993 | -0.011 | 0 | 0 |
| Belastingkosten
| 0 | 0 | -1.823 | -1.807 | -1.788 | -0.816 | 0.639 | 2.289 |
| Nettowinst
| -210.304 | -161.336 | -121.498 | -17.907 | -39.745 | 0.185 | -30.276 | -20.622 |
| Nettowinstmarge
| 0 | -102.111 | -12.545 | -2.365 | -0.95 | 0.003 | 0 | 0 |
| WPA (Winst Per Aandeel)
| -3.47 | -2.75 | -2.89 | -0.5 | -1.12 | 0.005 | -1.83 | -25.67 |
| Verwaterde WPA
| -3.47 | -2.75 | -2.89 | -0.5 | -1.12 | 0.005 | -1.83 | -25.67 |
| EBITDA
| -228.365 | -158.228 | -118.849 | -95.728 | -40.335 | -0.118 | -30.249 | -18.057 |
| EBITDA ratio
| 0 | -100.144 | -12.652 | -2.639 | -0.996 | -0.002 | 0 | 0 |